INTRODUCTION
Type-2 immunity and diseases associated with allergic inflammation afflict roughly 3-4 billion people worldwide, and CD4+ follicular T-helper (Tfh) cells and T-helper type-2 (Th2) cells are critical modulators of these responses. 1, 2 Tfh and Th2 cells orchestrate type-2 immunity through the production of type-2 cytokines. 3 Interleukin (IL)-4 from Tfh cells initiates B-cell classswitching to IgE and IgG1, and plays a role in the selection of high affinity antibodies. 4, 5 Th2 cells produce IL-4, IL-5, and IL-13, and mediate their effector function in the periphery by recruiting innate immune cells to mucosal tissues to support epithelial barrier function and integrity. Although much is known regarding the canonical signaling pathways used by Th2 cells to produce IL-4 and IL-13, comparatively little is understood with respect to how Tfh cells produce IL-4. 3 Furthermore, whether IL-4-producing Tfh and Th2 cells possess distinct developmental programs or share a common progenitor remains an area of continued interest in the development of type-2 immunity.
Tfh cells become competent to produce IL-4 protein in the absence of IL-4, 4, 6 and these cells express significantly lower amounts of GATA-3 messenger RNA (mRNA) and protein compared to conventional IL-4-expressing Th2 cells. 6, 7 As such, the canonical signaling pathways used by Th2 cells to achieve type-2 cytokine expression do not appear to be required for Tfhmediated IL-4 production. 3 Recent studies have identified the 3′ CNS2 enhancer of the il4 locus as being essential for IL-4 production by Tfh cells. Deletion of this region abrogates Tfhmediated IL-4 production and IgE class-switching. 8, 9 The CNS2 region harbors binding sites for various transcription factors including multiple sites for RBP-J, an important regulator of Notchmediated signaling. 10 Despite binding to the 3′ enhancer, the importance of Notch/RBP-J in IL-4 production by Tfh cells has been questioned. 8 However, the fact that RBP-J-deficiency in CD4 + T cells impacts IgE and IgG1 production along with the known function of RBP-J in CNS2-driven IL-4 expression by memory CD4 + T cells and IL-4-expressing iNKT cells suggests that a Notchdependent mechanism may play a more important role in IL-4 production by Tfh cells than previously appreciated. 10 Although Notch signaling has been studied extensively in other T-helper cell subsets, its role in Tfh cells is only starting to be elucidated. Formal evidence that Notch is playing a more general role in Tfh cell-mediated immunity comes from recent work showing that deletion of Notch1 and Notch2 in CD4+ T cells prevents the generation of Tfh cells. 11 The intrinsic nature of Notch signals being required for Tfh cell lineage commitment parallels findings in other T-helper cell subsets where Notch signaling facilitates cell fate choices. 12 Early studies proposed that distinct Notch ligands on dendritic cells could differentially instruct the development of specific T-helper cell subsets. 13, 14 Although the instruction model has been challenged, 15, 16 this seminal work laid the foundation to explore the nature of Notch ligands in T-helper cell differentiation and function. As a result, new, non-instruction-based models have emerged. These models advocate that Notch signaling serves as an unbiased amplifier helping to stabilize the cytokine profile already being established in differentiating CD4+ T cells. 17, 18 Using parasitic helminth infection as a robust model of type-2 immunity, we report that Notch signaling in CD4+ T cells is required for Tfh cell generation, IL-4 production, and IgE classswitching. The defect is specific to Tfh cells as Th2-mediated immunity, worm clearance, and IL-4 expression remained normal in the absence of Notch signaling. Furthermore, an unbiased approach to eliminate all functional Notch ligands using conditional deletion of the E3 ubiquitin ligase Mind bomb1 (Mib1) in dendritic cells, B cells, T cells, and follicular dendritic cell (FDC) shows that the source of Notch ligands driving Tfh cell differentiation can be distinct from the cells presenting or harboring cognate antigen during a prototypical type-2 immune response.
RESULTS

Deletion of Notch receptors in T cells results in abrogated humoral immunity but normal Th2-mediated immune hallmarks
To address the role of Notch signaling in the development of IL-4producing Th2 and Tfh cells during a type-2 immune response, we made use of IL-4 reporter mice (IL4 4get ), where Notch receptors are conditionally deleted in all T cells (CD4 cre Notch1/2 fl/fl ). 19, 20 The IL4 4get reporter background allows for IL-4 cytokine mRNA competency to be visualized through the production of green fluorescent protein (GFP).
To evaluate type-2 immunity, IL4 4get Notch1/2 fl/fl (wild-type) and IL4 4get CD4 cre Notch1/2 fl/fl (T cell-specific, Notch-deficient) mice were infected with the helminth Nippostrongylus brasiliensis. Intestinal worm burden, lung eosinophilia, and serum IgE were assessed 9 days post infection ( Fig. 1 ). In this model, defects in lung eosinophilia and helminth clearance are reflective of impaired Th2-mediated peripheral immunity, while defects in IgE production signify a defect in Tfh-mediated, type-2 humoral responses. 6, 21 Similar to wild-type mice, IL4 4get CD4 cre Notch1/2 fl/fl mice mounted a productive type-2 response in the periphery, as worms were cleared from the intestine and significant eosinophilia was observed in the lung (Fig. 1a, b ). In contrast, mice lacking Notch1 and Notch2 on T cells exhibited significantly decreased IgE levels relative to wild-type animals (Fig. 1c ). These data indicate that the absence of Notch signaling in T cells has little impact on Th2-mediated immune hallmarks in the periphery but a significant impact on Tfh-mediated immunity. This was not due to a defect in overall CD4+ T-cell numbers, as mice lacking Notch receptors on their T cells exhibited an overall increase in CD4+ T cells in both the periphery ( Supplementary Fig. S1a ) and the draining lymph nodes ( Supplementary Fig. S1b ) after helminth infection.
T-cell-specific deletion of Notch receptors leads to a selective reduction in IL-4 competent CD4+ T cells in the lymph nodes compared to the lungs after helminth infection Given that we observed normal worm clearance and eosinophilia but reduced IgE production in mice lacking Notch in T cells, we hypothesized that type-2 cytokine competency (mRNA expression) in Notch-deficient Th2 cells would remain intact, while IL-4competent Tfh cell number or function would be compromised. In support, mice that lacked expression of Notch in T cells showed normal numbers of IL-4 competent cells (IL4 4get GFP-reporter positive; IL-4 mRNA) in the lung, despite a decreased percentage of IL-4 competency within the total CD4+ T-cell pool ( Fig. 2a ). This is consistent with the higher number of CD4+ T cells found in the lungs of these mice after infection ( Supplementary Fig. S1a ). Despite normal Th2 cell generation, IL-4-expressing CD4+ T cells were significantly reduced in both percentage and number in the lung-draining mediastinal lymph nodes when Notch1 and Notch2 were deleted from T cells (Fig. 2b) .
These findings were further supported by histological analysis of IL-4-expression in the lung and lymph nodes. CD4+ GFPreporter staining in the lung was similar between both wild-type mice and animals lacking Notch1 and Notch2 in T cells (Fig. 3a ). The lack of GFP-reporter staining in tissue sections of mediastinal lymph nodes taken from IL4 4get CD4 cre Notch1/2 fl/fl mice confirms the paucity of IL-4 -expressing T cells in both the paracortex (IgD-) and B-cell follicles (IgD+) of the lymph nodes when Notch signaling is absent (Fig. 3b ). In sum, these data are consistent with a more pronounced role for Notch signaling in establishing type-2 cytokine competency in Tfh cells residing in the lymph nodes compared to lung-resident, canonical Th2 cells.
Tfh cell generation, IL-4 expression, and germinal center B-cell numbers are significantly reduced in mice that lack Notch in T cells Reduced serum IgE and IL-4 expression in the follicles of the mediastinal lymph nodes suggested that Tfh cell generation and/or function could be impacted by Notch-deficiency in T cells. In support, Tfh cells isolated from helminth-infected mice showed significantly increased Notch1 and Notch2 receptor expression relative to non-Tfh cells ( Supplementary Fig. S2a ). To directly investigate the necessity of Notch in Tfh cell generation, mediastinal lymph nodes were isolated from IL4 4get CD4 cre Notch1/2 fl/fl and IL4 4get Notch1/2 fl/fl mice 9 days after infection with N. brasiliensis, and CD4+ T cells were analyzed for canonical Tfh cell markers CXCR5 and PD-1 ( Fig. 4a ). T-cell Notch-deficiency results in a significant impairment in both the percentage and number of Tfh cells within the CD4+ T-cell compartment (Fig. 4a ). This result was confirmed as Notch-deficient CD4+ T cells from the mediastinal lymph nodes showed a marked deficit in expression of the Tfh cell lineage-determining factor BCL6 by percent and mean fluorescent intensity (MFI) ( Supplementary Fig. S3a ). GATA3, a key lineagedetermining factor for Th2 commitment, was not significantly changed in percentage or MFI ( Supplementary Fig. S3b ).
Regarding an effect on IL-4 mRNA expression, in the few CXCR5+, PD1+ cells phenotypically resembling Tfh cells generated in infected IL4 4get CD4 cre Notch1/2 fl/fl mice, we observed a tenfold reduction in GFP (IL-4) reporter expression compared to Notchsufficient T cells (Fig. 4b ). This deficiency in Tfh cells and Tfh-derived IL-4 corresponded to impaired germinal center B-cell generation, an event largely dependent on Tfh cells in this model ( Fig. 4c ). Altogether, these data identify Notch signaling as a key component in Tfh cell generation and function during type-2 immunity.
Because the deletion of both Notch1 and 2 resulted in an almost complete loss of Tfh cells, it was difficult to fully assess the role of Notch signaling in IL-4 expression by Tfh cells. To circumvent this issue, we made use of an intermediate phenotype observed in mice that lack Notch1 but retain one allele of Notch2. This led to an intermediate loss of Tfh cells compared to Notch-sufficient and Notch1/2-deficient CD4+ T cells ( Fig. 5a ). Importantly, the Tfh cells generated in the absence of Notch1 still exhibited a significant impairment in IL-4 mRNA expression ( Fig. 5b ). In line with these results, elimination of Notch1 alone in T cells caused a moderate reduction in germinal center B-cell generation ( Fig. 5c ).
To further investigate the role of Notch signaling in the expression of IL-4 by Tfh cells, we employed the use of a gamma secretase inhibitor (GSI) to inhibit Notch signaling in already differentiated Tfh cells. IL4 4get/KN2 mice immunized with ovalbumin (OVA) precipitated in alum generate abundant Tfh cells by 7-10 days after subcutaneous immunization. 4 Using this model, OVA immunized mice were given injections of GSI or a mock injection on days 7, 8, and 9 post immunization. Mice that received the GSI had a reduction in both their percentage and number of Tfh cells (Supplementary Figs. S4a and S5a). Importantly, IL-4 protein production by Tfh cells in mice that received GSI was significantly reduced compared to mice that received a mock injection ( Supplementary Fig. S4b ). Thus, both the absence of Notch1 and the blocking of Notch signaling in established Tfh cells results in reduced Tfh cell numbers and IL-4 expression among the remaining Tfh cells.
BCL6, BATF, IRF4, and cMaf all play important roles in Tfh cell differentiation. [21] [22] [23] [24] [25] [26] Many of these factors also have been suggested to play a role in IL-4 expression by Tfh cells. 21, 22 To assess if Notch signaling influences these Tfh lineage-factors, we again generated Tfh cells and gave GSI or a mock injection on days 7, 8, and 9 before performing intracellular transcription factor staining. GSI treatment led to decreased c-Maf expression among BCL6+, PD1 high Tfh cells (Supplementary Figs. S5b and S6b), while the expression of IRF4 and BATF was not significantly changed ( Supplementary Figs. S5c, d and S6c, d). C-Maf is known to regulate IL-4 expression in Th2 cells, but its role in Tfh-driven IL-4 expression is unclear. 26 
Over-expression of Notch intracellular domain increases recent IL-4 protein production in Tfh cells
The data demonstrate that Notch-deficiency in T cells leads to impaired Tfh cell generation and an impaired ability to establish IL-4 mRNA competency within those cells. To better uncouple the role of Notch in Tfh generation from its role in Tfh-derived IL-4 production, we investigated whether additional Notch signaling would lead to increased IL-4 protein production in Tfh cells. To do this, IL4 KN2 reporter mice, 27 which report recent IL-4 protein production through the expression of human CD2 at the cell surface, were crossed with a tamoxifen-inducible GFP-NICD fusion reporter line. 28 In this IL4 KN2 ER cre Rosa26 Stop-flox-NICD-GFP gain-of-function system, it is possible to directly compare IL-4 protein production in Tfh cells experiencing endogenous Notch signals relative to those experiencing increased Notch signaling in the same lymph node based on the presence or absence of GFP expression. IL4 KN2 ER cre Rosa26 Stop-flox-NICD-GFP mice were treated with tamoxifen 3 days prior to N. brasiliensis infection, and mediastinal lymph nodes and lungs from mice were analyzed 9 days post infection ( Fig. 6a ). IL-4 protein production, as marked by human CD2, was comparable between CD4+ T cells-expressing endogenous NICD (GFP negative) and those over-expressing NICD (GFP-positive) in the lung (Fig. 6b ). In contrast, Tfh cells from the mediastinal lymph nodes of these same animals showed a significant twofold enhancement of IL-4 production when the GFP-NICD fusion was induced ( Fig. 6c ). Over-expression of NICD also led to an increase in the percentage of non-Tfh cells producing IL-4 in the lymph node ( Supplementary Fig. S7a, b ). In addition, NICD gain-of-function also led to increased BCL6 and GATA3 expression in lymph node CD4+ T cells (Supplementary Fig. S8a, b ). This finding is consistent with Notch signaling affecting GATA3 expression, as previously shown during in vitro Th2 cultures, 19, 29 but also highlights a role for Notch signaling in mediating BCL6+ Tfh cell generation or maintenance. 6 BCL6 and GATA3 in lung CD4+ T cells was not altered in cells overexpressing NICD ( Supplementary Fig. S8c, d ). Altogether, these data show that Notch signaling impacts not only Tfh cell development but also IL-4 production by Tfh cells. The observation that over-expression of NICD has a more pronounced effect on IL-4 production and transcriptional regulation in Tfh cells compared to lung Th2 cells further supports a more selective role for Notch signaling in Tfh cells relative to their Th2 cell counterparts.
Functional Notch ligands on conventional dendritic cells can influence Tfh cell fate early during CD4+ T-cell differentiation, but are not required for full Tfh commitment Although high doses of antigen can drive a Tfh cell fate in the absence of conventional dendritic cells (cDC), the initiation of Tfh cell fate often requires antigen presentation by conventional dendritic (cDC) cells in more physiologic settings. [30] [31] [32] To assess whether early Tfh cell commitment required functional Notch ligands on cDC subsets, canonical Notch ligand-mediated signaling was prevented by conditionally deleting the E3 ubiquitin ligase molecule, Mind bomb1 (Mib1), in cDC. Notch signaling requires Mib1 for ligand-induced Notch signaling in vertebrates. 33 Deletion in dendritic cells was achieved by CD11c-driven, Cre recombinase-mediated excision of loxP-flanked Mib1. 34, 35 Cre recombinase expression in cDC was confirmed by assessing yellow fluorescent protein (YFP) expression among CD11c+, MHCII+ cells isolated from the mediastinal lymph nodes of N. brasiliensisinfected CD11c Cre Rosa flox-stopYFP mice ( Supplementary Fig. S9a ). Mib1 deletion using the CD11c Cre Mib1 fl/fl system was confirmed by PCR analysis of dendritic cells isolated and sorted from the mediastinal lymph nodes 5 days after N. brasiliensis infection ( Supplementary Fig. S9b ) and bone marrow-derived DC cultures ( Supplementary Fig. S9c ).
To assess changes in IL-4 competency and Tfh development in the absence of Mib1 in cDC, we crossed CD11c Cre Mib1 fl/fl mice onto the IL4 4get reporter system. IL4 4get CD11c Cre Mib1 fl/fl (Mib1deficient cDC) and IL4 4get Mib1 fl/fl (wild-type) mice were infected with N. brasiliensis. Mediastinal lymph nodes were isolated on day Notch signaling represents an important checkpoint... 5 and day 9 post infection. On day 5, mice lacking Mib1 in CD11cexpressing cells showed a significant decrease in the percentage and total number of CD4+ T cells expressing the canonical Tfh markers CXCR5+ , PD-1+ ( Fig. 7a ). Although the percentage of Tfh cells-expressing IL-4 mRNA were similar between mice harboring Mib1-deficient cDC and wild-type cDC, the numbers of IL-4 competent Tfh cells were reduced as would be expected given the decrease in total Tfh cells ( Fig. 7a, b ). However, the dependence on functional Notch-ligands provided by cDC was not absolute as Tfh cell numbers and IL-4 mRNA competency were similar by day 9 of infection ( Fig. 7c and Supplementary Fig. S10a, b) .
The defect observed at day 5 was not due to a general priming defect as IL4 4get OT-II CD4+ T cells transferred into CD11c cre MIB1 fl/fl mice did not have a significant defect in their proliferation compared to OT-II T cells transferred into control MIB1 fl/fl mice ( Supplementary Fig. S11a ). The transferred cells also had no defect in the expression of early activation markers ( Supplementary Fig. S11b ). Consistent with the previous findings in Tfh cells, OT-II T cells transferred into CD11c cre MIB1 fl/fl mice exhibited no reduction in the percentage of cells that established IL4 mRNA competency ( Supplementary Fig. S11c ).
Functional Notch ligands on B cells and follicular dendritic cells are not required for Tfh cell commitment
Although cDCs often play an important role in the early development of Tfh cells, entry of Tfh cells into the B-cell follicles and interaction with B cells themselves appears critical for ultimate Tfh cell commitment. 31 Furthermore, depletion of FDC impacts Tfh cell numbers. 36 Given that functional Notch ligands on cDC were not required for Tfh cell commitment after day 5, we pursued the idea that B cells or FDC in the follicles might be the compensatory source of these ligands as the cellular response to N. brasiliensis matured. To investigate this mechanism, we conditionally deleted Mib1 in B cells and FDC using a CD21driven Cre recombinase. 37 CD21 is confined to these two cell types in the mouse immune system, 38 and the specificity of CD21-Cre recombinase activity has been confirmed in both B cells and FDC using this system. 36, 37 To confirm CD21-Cre activity in FDC and B cells in our hands, we immunized CD21 cre Rosa26 Stop-flox-YFP mice with OVA precipitated in alum at three sites in the back and collected draining axillary, brachial, and inguinal lymph nodes 5 days post injection. Similar to previous reports, Cre-activity was confirmed in 87.1% of the B cells by YFP expression (Fig. 8a) . Using flow cytometry, we observed that CD21-cre-activity was highly enriched in FDCs compared to other stromal populations based on YFP expression ( Fig. 8b) . Using immunohistochemistry on CD21 cre Rosa26 Stop-flox-YFP mice, we confirmed CD21-cre-activity in FDC and B cells by staining for YFP in tissue sections obtained from isolated lymph nodes (Fig. 8c ). YFP was co-expressed by both IgD+ (B cells) cells, as well as FDCM2+ (FDC) cells in the IgD-germinal center (Fig. 8c) .
To assess whether functional Notch ligands on B cells and FDC are required for Tfh commitment, IL4 4get CD21 Cre Mib1 fl/fl (Mib1deficient B cells and FDC) or IL4 4get Mib1 fl/fl (wild-type) mice were infected with N. brasiliensis, and mediastinal lymph nodes were isolated 9 days later. Both CXCR5+, PD1+ Tfh cell percentages and numbers were similar to mice where B cells and FDC remained Mib1 competent (Fig. 9a ). There was also no significant change in IL-4 mRNA competency among the Tfh cell compartment, as percentage and number of GFP expressing cells remained similar between these two groups (Fig. 9b) . T-cell-specific deletion of Mib1 also had no impact on Tfh cell numbers or IL-4 potential ( Supplementary Fig. S12a, b ). To summarize, functional Notch ligands on cDCs influence early Tfh cell fate and cytokine competency. However, functional ligands on non-hematopoietic cells other than FDC are sufficient in the absence of functional ligands on dendritic cells as the immune response proceeds.
DISCUSSION
In these studies, we establish that Notch signaling in CD4+ T cells represents an important checkpoint in the bifurcation between Tfh cell-and Th2 cell-driven hallmarks of type-2 immunity. Notch receptors 1 and 2 are required for Tfh cell generation, but are largely dispensable for Th2 differentiation in response to parasitic helminth infection. The importance of Notch in this bifurcation is reflected in the biology, as Tfh-mediated type-2 humoral hallmarks, such as IgE production, were impaired, while Th2orchestrated peripheral immunity, marked by worm clearance in the intestine and innate cell recruitment to the lung, remained intact. Furthermore, these studies reveal that Notch signaling is not only required for development and commitment of Tfh cells, but that Notch signals can enhance type-2 cytokine production in committed Tfh cells. The enhanced cytokine production that results from increased NICD expression also appears specific to Tfh cells as lung-resident CD4+ T cells over-expressing NICD produced similar levels of IL-4 as CD4+ T cells-expressing endogenous NICD.
Many factors including BCL6, BATF, ASCL2, ICOS, and c-Maf have been deemed essential for Tfh cell development. 21, 22, 39 These factors are part of a developmental circuit, which helps to determine Tfh cell fate. 39 However, Notch has largely been left out of this conversation despite its requirement in Tfh development. 11 Here, we show further evidence supporting a role for Notch in the Tfh developmental circuit, as inhibition of Notch signaling leads to decreased expression of c-Maf in Tfh cells. Of note, BATF, c-Maf, and RBP-J have all been reported to bind at the CNS2 enhancer of the IL-4 locus. Given the importance of the CNS2 region in the expression of IL-4 by Tfh cells, a likely mechanism as to how Notch signaling modulates the IL-4 in Tfh cells is via NICD binding to RBP-J to modulate IL-4 expression. Whether and how RBP-J and NICD interact with c-Maf and BATF at this site is not known. As such, further work investigating how Notch selectively mediates cell fate and influences type-2 cytokine potential in the context of these other factors will be an important next step in understanding Tfh cell generation and function.
Two competing models for Notch in Th1, Th2, and Th17 cell differentiation have emerged, and are also likely at play in Tfh cell fate determination. The unbiased amplifying or facilitating model implies that Notch signals potentiate an already established cytokine potential in developing subsets. 17 The instructive model suggests that the signals from the engagement of different Notch ligands by Notch receptors can direct differentiation toward a specific cell fate. 13 Importantly, the results herein support aspects of both amplifying and instructive mechanisms in Notch-driven Tfh cell fate and function. As discussed above, over-expression of NICD showed that Notch signaling enhances IL-4 production in Tfh, but not Th2 cells. Furthermore, over-expression of NICD had no effect on driving GATA-3 expression in lung CD4+ T cells, while it did lead to enhanced expression of BCL6 in lymph node CD4+ T cells. The selective dependence on Notch ligands in Tfh vs. Th2 cell generation also reveals the potential presence of an instructivebased mechanism for Notch in Tfh cell fate choice. In its simplest form, the presence of functional Notch ligands promotes Tfh cell fate, but has a significantly reduced influence on Th2 cell development. This is not to say that Notch does not have a role in GATA3 expression or in amplifying Th2 cytokine competency, but rather that Th2 cells do not rely on Notch signals in vivo to the same extent as Tfh cells to achieve their ultimate effector fate. It is likely that Th2 cell fate is cemented and less influenced by Notch signals once a threshold of GATA-3 expression is achieved in developing Th2 cells. The presence of other IL-4 and IL-13 producers in the lung can reinforce the Th2 phenotype and maintenance of GATA-3 in Th2 cells, potentially making the role of Notch in these settings less critical for driving Th2 responses in the periphery. While we did not see major defects in peripheral Th2 responses in mice with Notch-deficient T cells, we did observe an influx of non-Th2 CD4+ T cells in the lungs of these mice. Given that Notch has been shown to influence fate and function in Th1, Th2, and Th17 cells, future work investigating the effector fate and transcriptional program of these non-Th2 cells is of great interest.
The near complete absence of Tfh cells and IgE, despite normal Th2 development and peripheral type-2 immunity in mucosal tissues observed in this study is intriguing given conclusions made by prior studies. Several past studies looking at the necessity of Notch in type-2 immune responses have described Notch signaling to be essential for Th2 biology. 40 These prior studies largely based their conclusions on in vitro Th2 polarization assays, ex vivo restimulation of lymph node resident CD4+ T cells, or used serum cytokines and IgE as surrogates for Th2 function. We now know that these readouts are not particularly good indicators of true Th2 cell biology in vivo. For example, IgE is dependent on Tfhderived IL-4 not type-2 cytokines generated by Th2 cells. 4 Thus, prior studies designed to uncover a role for Notch in Th2 cell biology may have instead identified unappreciated defects in Tfh cells. We believe the experiments shown herein help to reconcile prior results and place them in a more unifying context.
The findings shown herein are of particular interest in light of previous studies investigating the role of Notch during Trichuris muris infection, another nematode infection model that requires Th2 cells for parasite expulsion. 17, 41 While in the N. brasiliensis model we saw normal worm clearance but a complete loss of IgE when T cells lacked Notch1 and Notch2 suggesting normal Th2 function but impaired Tfh function, the T. muris studies showed both a loss of IgE and impaired worm expulsion when T cells expressed a dominant negative form of the co-activator mastermind/MAML (DNMAML), which is considered a pan-Notch inhibitor. This might at first pass suggest that both Tfh and Th2 cells are impaired using the condition DNMAML system. However, the authors show that administration of anti-CD3 to activate T cells in T. muris infected mice elicited no significant change in IL-4, IL-5, and IL-13 in the serum compared to wild-type. This is consistent with Th2 differentiation and type-2 cytokine competency remaining largely intact in this setting. It will be interesting to confirm this by directly assessing Tfh cell and Th2 cell development in this model. Taken together, the data suggests that Notch signaling plays a less critical role in Th2 compared to Tfh differentiation, but supports a role for Notch in amplifying and optimizing Th2 function.
Another interesting area of investigation will be to determine why inhibition of Notch signaling seems to impair IL-4-mediated antibody isotypes more readily than interferon (IFN)-gammadriven isotype-switching. 19, 41, 42 One might expect Notch to affect both IL-4-producing and IFN-gamma-producing Tfh cells equally as both are found in the germinal centers and affect isotypeswitiching. 4 In support of Notch being involved in the generation of Tfh cells in both Th2 and Th1 settings, chronic Leishmania infection models show that Notch1 and Notch2-deficiency in T cells leads to diminished Tfh cells and Tfh-dependent germinal center formation even in settings of robust type-1 responses. Of note, L. major infection of CD4 cre Notch1/2 fl/fl mice did not affect Th2 cell generation as Notch1/Notch2-deficiency in T cells promoted lesion development on the normally resistant C57BL/6 background. 43 Lesion development is dependent on the presence of IL-4-producing Th2 cells. However, these findings do suggest that Th1 cell function was impacted in the absence of Notch signaling as their presence would prevent lesion development in this model.
Curiously, blocking of IFN-γ seems to rescue IgE and IgG1 production in T. muris infected mice expressing a dominant negative form of MAML in T cells. Whether IFN-gamma is impacting Tfh cells directly in this case to promote IgE is not clear. It is likely that IFN-gamma from Th1 cells is suppressing systemic levels of type-2 cytokines derived from Th2 cells during chronic helminth infection. Once inhibited by antibody, IFNgamma can no longer suppress Th2 function allowing systemic IL-4 and non-Tfh-dervied IL-4 to influence B cells. 44, 45 This finding, along with the data discussed above, may also suggest the presence of a non-canonical Notch signaling pathway that differentially involves MAML during Th1, Th2, and Tfh cell generation. Investigating these possibilities will be important for future studies.
The unexpected finding that Th2 cells were less dependent on Notch signals than their IL-4-producing Tfh cell counterparts suggested that these two cell subsets may also require distinct Notch ligands. One such bifurcating-ligand maybe DLL4. Inhibition of DLL4 promotes Th2 cell function in settings of allergic airway inflammation. 46, 47 The inhibitory role for DLL4 on Th2 cells is particularly intriguing given that DLL4 serves a promoting role in Tfh cell differentiation. 48 When placed in the context of the data presented here, it is consistent with DLL4 acting as a switch for Tfh cell differentiation. In its absence, responding IL-4 competent cells may default toward a Th2 cell fate. DLL4 acting as a specific trigger for Tfh cells would also be consistent with our Mib1 results, as Mib1 has the highest affinity for DLL4 and is known to play a key role in DLL4-mediated Notch1 signaling during T-cell lineage development. 49, 50 How and if Notch signals complement TCR signals to direct Tfh cell fate is an interesting area for future investigation. The affinity of the TCR for antigen-MHC complexes and the dwell time spent on antigen presenting cell, are key factors in ultimately determining Tfh cell fate. 51, 52 However, additional signals likely influence Tfh cell fate either by increasing dwell time, and/or tuning TCR signals, or by independently promoting a Tfh-specific gene circuit in parallel to TCR signaling. 39 In support of a complementary or parallel role for Notch in TCR-mediated differentiation of Tfh cells, previous studies have shown that TCR signaling increases Notch receptor expression and activation, and that Notch is required for TCR-mediated activation and proliferation of peripheral T cells. 53, 54 It is also clear that Notch signals can potentiate or inhibit TCR signals in the thymus and the periphery to regulate T-cell fate. 55, 56 The advantage of using Mib1 deletion is that it disrupts downstream signaling from all Notch ligands. Thus, it provides an unbiased approach to assess the involvement of Notch ligands in biology. However, as discussed above with regard to DLL4 in Th2 and Tfh cell generation, this prevents investigation into the individual roles specific Notch ligands might play in type-2 immunity. It is also unable to assess a role for non-canonical Notch ligands as Mib1 may not disrupt non-canonical Notch signaling. Despite these caveats, our findings do show that cDCs provide an important early source of Notch ligands. However, functional Notch ligands on cDC are not necessary to establish full Tfh cell effector potential. Similarly, B cells, T cells, and FDC, which interact frequently with Tfh cells in the B-cell follicles and germinal centers, are not required sources of Notch ligands for Tfh cell commitment.
These findings help to further support a fibroblastic cell source of DLL4 as critical for Tfh cell commitment. 48 Although initially suggested to be FDC, 48 our data indicates that other stromal sources are sufficient for Tfh commitment. Notch ligands on cDC, FDC, and B cells may contribute to the Tfh phenotype, but other (likely stromal sources) of Notch ligands can compensate in their absence.
This study places Notch in the company of BCL6 and ASCL2 as factors that selectively regulate Tfh cell development and function relative to Th2 cells. However, unlike BCL6 and ASCL2, which work intracellularly to control Tfh cell fate, Notch and its ligands are present at the cell surface. This suggests that Notch and/or its ligands could represent important targets for immune-mediated therapies such as biologics focused on Tfhmediated disease outcomes, including allergies and other IgEdriven pathology.
MATERIALS AND METHODS
Mice C57BL/6 Notch-1 fl/fl mice, 57 Notch-2 fl/fl , 58 CD4 cre , 59 Rosa26 flox-stop-YFP , 60 CD21 cre , 61 Rosa26 Stop-flox-NICD-GFP , 28 ER cre , 62 and C57BL/6 mice were purchased from Jackson laboratories. MIB1 fl/fl were generated by Young-Yun Kong (Pohang University of Science and Technology) and rederived at Duke University. 35 CD11c cre mice were provided by Gianna Hammer (Duke University). 34 IL-4 4get and IL-4 KN2 mice were provided by Richard Locksley (UCSF). 20, 27 OT-II mice were provided by Weiguo Zhang (Duke). All mice were housed in pathogen-free facilities following guidelines set by the Division of Laboratory Animal Resources, Duke University Medical Center, Biological Resource Center at National Jewish Health, and the Institutional Animal Care and Use Committee.
Infections and worm counts N. brasiliensis was prepared as previously described. 63 Mice were injected subcutaneously in the rear flank with 500 L3 larvae in saline solution. To conduct worm counts, small intestines were removed, opened longitudinally, and incubated in HBSS at 37°C for 1-2 h. Adult worms were manually enumerated. Notch inhibition studies Where described, mice were immunized subcutaneously with 100 µg of OVA emulsified in alum in the footpad. On days 7, 8, and 9 post immunization mice were given GSI, Dibenzazepine (Selleckhem) intraperitoneally. The popliteal lymph node was harvested on day 10 for subsequent flow cytometric analysis.
Tamoxifen injections
Tamoxifen (T5648; Sigma) was diluted in USP grade corn oil. Two milligrams of tamoxifen was injected intraperitoneally once every 24 h for 3 days prior to infection.
Cell proliferation study OT-II CD4+ T cells were isolated and stained with 5 µM eFluor670 proliferation dye (65-0840-85; Thermo Fisher). In all, 1.5 × 10 6 OT-II T cells were then transferred I.V. into the mice described. Twentyfour hours post transfer the mice were immunized by subcutaneous injection of 100 ug of OVA emulsified alum in the footpad. Three days post immunization, the popliteal lymph nodes were harvested to assess proliferation of the transferred cells.
Immunofluorescence histology
Lymph nodes were fixed with 4% PFA for 2 h, incubated in 30% sucrose, and frozen in optimal cutting temperature compound (O.C.T.). Lungs were inflated with, then incubated in 4% PFA for 3 h, and incubated in 30% sucrose prior to freezing. Eight micron sections were cut and epitopes on slides were stained using tyramide amplification as described. 21 eGFP and YFP were detected using a purified polyclonal rabbit anti-mouse GFP (NB600-308; Novus Biologicals) followed by biotinylated F(ab') 2 donkey anti-rabbit (Jackson ImmunoResearch Laboratories). Biotinylated anti-mouse CD4 (RM4-5; Biolegend); IgD (11-26c; eBiosciences), and FDCM2 (212-MK-2FDCM2; ImmunoKontact) were used to detect CD4 T cells, B cells, and FDC, respectively. 4′,6-Diamidine-2′-phenylindole dihydrochloride (DAPI; 0.5 µg/ml; Roche) in PBS was used to counterstain nuclei prior to mounting on coverslips with Vectashield (Vector laboratories). Images were collected with a Zeiss Axio Imager. Analysis of images was performed using FIJI (ImageJ) software.
collected on a FACSCanto II or LSR II (BD Biosciences) cytometer and analyzed using FlowJo (TreeStar).
Transcription factor staining Surface stains were performed followed by staining of dead cells with Fixable Violet Dead Cell Stain kit (L34964; Thermo Fisher). A Foxp3 transcription factor staining buffer kit (eBioscience) was used to fix and permeabilize cells. Finally, these antibodies were used for transcription factor staining PEconjugated to anti-mouse/human GATA-3 (TWAJ; eBioisciences), anti-mouse/human cMAF (SymOF1; eBiosciences), anti-mouse/ human IRF4 (3E4; eBiosciences), anti-mouse/human BATF (9B5A13); and Alexa Fluor 647 conjugated to anti-mouse BCL6 (K112-91; BD Biosciences).
FDC isolation CD21 cre Rosa26 Stop-flox-YFP and Rosa26 Stop-flox-YFP mice were immunized subcutaneously with OVA emulsified in Imject alum (Thermo Fisher) in both rear flanks and upper back. Each mouse received a total of 100 µg of OVA/alum. Mice were sacrificed and axial, brachial, and inguinal nodes were harvested. Lymph nodes were opened using 26G needles and digested at 37°C for 30 min with Collagenase IV (1 mg/ml; 17104-019; Gibco); DNase I (40 µg/ml; DN25; Sigma) in RPMI 1640. Pipetting was performed every 10 min to assist in digestion of the tissue. After incubation, 5 mM EDTA (03690; Sigma) was added to the digestion to help dissociate cell aggregates. Cells were filtered through an 80 µm mesh. StemCell RapidSpheres (19860 A) kit was used to positively select CD45+ cells using biotinylated anti-mouse CD45 (30F11; Biolegend). Flow through, highly enriched for CD45-cells, was taken and stained for flow cytometry.
To image FDCs by immunofluorescence histology, CD21 cre R-osa26 Stop-flox-YFP and Rosa26 Stop-flox-YFP mice were immunized subcutaneously in the footpad with 100 µg OVA emulsified in alum. The popliteal lymph node was harvested 9 days later and prepared for histologic analysis. Staining for FDCM2 was performed to specifically identify FDCs.
Enzyme-linked immunosorbent assay (ELISA) Ninety-six well plates were coated with rat anti-mouse IgE (R35-72; BD Bioscience) and blocked using 5% BSA. Serum samples were added and total IgE detected using biotinylated antimouse IgE (R35-118; BD Biosciences) followed by streptavidin-HRP and o-phenylenediamine. An EMax Precision Microplate Reader (Molecular Devices) was used to quantify total IgE concentrations based on purified IgE (MEB-38; Biolegend) standard curves.
Real-time PCR CD11c+ MHCII+ DCs were sorted with a BD FACSAria Fusion or Astrios (Beckman Coulter) and resuspended in TRIzol reagent (15596026; Thermo Fisher). Chloroform and ethanol precipitation were used to isolate RNA from the samples. DNA was eliminated using a DNase I kit (18068015; Thermo Fisher). cDNA was synthesized by reverse transcription (18080051; Thermo Fisher) per kit instructions with oligo (dT) primers followed by RNase H treatment. Real-time PCR was performed on the cDNA using an allin-one SYBR green qPCR mix (QP001-01; GeneCopoeia) amplified with primers against Mind bomb1 (QT00110453; Qiagen) and β-actin (QT00519526; Qiagen) on an Applied Biosystems StepO-nePlus RT PCR system. Expression of Mind bomb1 was calculated relative to β-actin.
Statistics
Two-tailed paired or unpaired t-tests were performed. P-values <0.05 and >0.01 are indicated with a single asterisk (*), P-values <0.01 and >0.001 are indicated with double asterisk (**), and Pvalues <0.001 are indicated with triple asterisk (***).
